TP53 Mutations in Serous Tubal Intraepithelial Carcinoma and Concurrent Ovarian High-Grade Serous Carcinoma

被引：0
|
作者：
Kuhn, E.
Kurman, R. J.
Soslow, R. A.
Han, G.
Wang, T-L
Shih, I-M
机构：
[1] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
MODERN PATHOLOGY | 2011年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1074
引用
收藏
页码：253A / 254A
页数：2
相关论文
共 50 条
  • [1] TP53 Mutations in Serous Tubal Intraepithelial Carcinoma and Concurrent Ovarian High-Grade Serous Carcinoma
    Kuhn, E.
    Kurman, R. J.
    Saslow, R. A.
    Han, G.
    Wang, T-L
    Shih, I-M
    [J]. LABORATORY INVESTIGATION, 2011, 91 : 253A - 254A
  • [2] TP53 mutations in serous tubal intraepithelial carcinoma, the putative precursor lesion of ovarian high-grade serous carcinoma
    Kuhn, Elisabetta
    Kurman, Robert J.
    Soslow, Robert A.
    Han, Guangming
    Wang, Tian-Li
    Shih, Le-Ming
    [J]. CANCER RESEARCH, 2011, 71
  • [3] TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma-evidence supporting the clonal relationship of the two lesions
    Kuhn, Elisabetta
    Kurman, Robert J.
    Vang, Russell
    Sehdev, Ann Smith
    Han, Guangming
    Soslow, Robert
    Wang, Tian-Li
    Shih, Ie-Ming
    [J]. JOURNAL OF PATHOLOGY, 2012, 226 (03): : 421 - 426
  • [4] Proliferative Activity in Serous Tubal Intraepithelial Carcinoma Compare to Adjacent Normal Tubal Epithelium and Concurrent High-Grade Serous Carcinoma
    Kuhn, E.
    Kurman, R. J.
    Sehdev, A. E. Smith
    Shih, I-M
    [J]. LABORATORY INVESTIGATION, 2011, 91 : 254A - 254A
  • [5] TP53 mutations and the association with platinum resistance in high grade serous ovarian carcinoma
    Montemorano, Lauren
    Shultz, Zoey B.
    Farooque, Alma
    Hyun, Meredith
    Chappell, Richard J.
    Hartenbach, Ellen M.
    Lang, Jessica D.
    [J]. GYNECOLOGIC ONCOLOGY, 2024, 186 : 26 - 34
  • [6] Proliferative Activity in Serous Tubal Intraepithelial Carcinoma Compare to Adjacent Normal Tubal Epithelium and Concurrent High-Grade Serous Carcinoma
    Kuhn, E.
    Kurman, R. J.
    Sehdev, A. E. Smith
    Shih, I-M
    [J]. MODERN PATHOLOGY, 2011, 24 : 254A - 254A
  • [7] Advances in serous tubal intraepithelial carcinoma: correlation with high grade serous carcinoma and ovarian carcinogenesis
    Li, Hong-Xia
    Lu, Zhao-Hui
    Shen, Keng
    Cheng, Wen-Jun
    Malpica, Anais
    Zhang, Jing
    Wei, Jian-Jun
    Zhang, Zhi-Hong
    Liu, Jinsong
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (03): : 848 - 857
  • [8] The effect of germline polymorphisms on somatic hotspot mutations in TP53 for the treatment of high-grade serous ovarian carcinoma
    De Souza, Cristabelle Madona N.
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [9] High-grade serous Ovarian Cancer: TP53 Mutations and Platinum Response
    Lorenz, Judith
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2024, 84 (07)
  • [10] Combination of TP53 and AGR3 to distinguish ovarian high-grade serous carcinoma from low-grade serous carcinoma
    Qiu, Chunping
    Wang, Yu
    Wang, Xiao
    Zhang, Qing
    Li, Yinuo
    Xu, Ying
    Jin, Chengjuan
    Bu, Hualei
    Zheng, Wenxin
    Yang, Xingsheng
    Lu, Nan
    Kong, Beihua
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 52 (06) : 2041 - 2050
12345